Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Alexion Pharmaceuticals, Inc. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
acute-kidney-injurycomplement
thrombotic microangiopathy, complement, trigger, secondary thrombotic microangiopathy, acute kidney injury, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 847291
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.